Current Status and Challenges of Interventional Therapy for Diagnosis and Treatment of Arrhythmia in China

There are a large number of arrhythmia patients in China, and the field of interventional therapy for the diagnosis and treatment of arrhythmia has developed rapidly and made remarkable achievements. It is currently in a steady growth trend. In 2021, a total of 99,306 cases of pacemaker, 6547 cases of implantable cardioverter defibrillator, 5333 cases of cardiac resynchronization therapy, and 210,609 cases of catheter ablation were registered in the direct reporting system of arrhythmia interventional therapy information network, all of which increased significantly relative to those in 2020. However, there remains a considerable gap when in comparison with advanced countries. Therefore, there is an urgent need to widely implement and standardize advanced arrhythmia diagnosis and treatment techniques. In the future, it is vital to improve the training and development of arrhythmia physicians and teams, advance graded diagnosis and treatment, and foster international cooperation. In addition, there is a growing demand for increased clinical research to guide practical applications and the promotion of new technologies and devices for arrhythmia diagnosis and treatment.